News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Wellness.
RELATED STOCKHEAD STORIES
News
Cannabis stocks take a well-earned breather after days of strong gains
News
Capital Raisings Recap: Another 103 deals and $2.68bn+ raised on the ASX in November
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Here’s why hemp is a unique opportunity within the cannabis sector; and who’s in it on the ASX
Health & Biotech
Weed Week: ‘Lame duck’ US Congress set to vote on key cannabis bill
News
Closing Bell: Today’s biggest small cap movers on the ASX
Experts
ScoPo’s powerplays: ‘The vibe feels good’
IPO Watch
2018 ASX IPOs are doing much better two years on
Health & Biotech
The ASX pot stocks looking to get high on Canada’s $3bn market
Health & Biotech
ASX pot stocks are getting high after TGA interim ruling
News
Elixinol Global looks to emerge from the ashes of cannabis collapse
News
Which stocks could be hit by tax loss selling as end of financial year looms?
Health & Biotech
Weed Week: Cannabis for kids? UK baby participates in world-first treatment
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX companies needing capital urged to ‘act now’ before funding dries up
News
